DUBLIN–(BUSINESS WIRE)–The “Tuberculosis Testing – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Tuberculosis Testing Market to Reach $2.6 Billion by 2027
Amid the COVID-19 crisis, the global market for Tuberculosis Testing estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.6 Billion by 2027, growing at a CAGR of 5.1% over the period 2020-2027. Culture-Based Tests, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$634.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chest X-Ray segment is readjusted to a revised 3.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $117.7 Million, While China is Forecast to Grow at 5.4% CAGR
The Tuberculosis Testing market in the U.S. is estimated at US$117.7 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$330.1 Million by the year 2027 trailing a CAGR of 5.4% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.1 Billion by the year 2027.
Interferon-Gamma Release Assay (IGRA) Segment to Record 6.5% CAGR
In the global Interferon-Gamma Release Assay (IGRA) segment, USA, Canada, Japan, China and Europe will drive the 6.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$47.8 Million in the year 2020 will reach a projected size of US$69.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 6.2% CAGR through the analysis period.
Select Competitors (Total 55 Featured)
Abbott Laboratories, Inc.
Akonni Biosystems, Inc.
Alere, Inc.
Becton, Dickinson and Company
bioMerieux SA
Cepheid, Inc.
Creative Diagnostics
Danaher Corporation
Epistem Ltd.
F. Hoffmann-La Roche AG
Hain Lifescience GmbH
Hologic, Inc.
Lionex GmbH
Oxford Immunotec Ltd.
Qiagen NV
Thermo Fisher Scientific, Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Year 2021 in Review and Near-term Outlook
COVID-19 Unravels Progress against Tuberculosis & Pushes Mortality for First Time in a Decade
Low Funding Remains Palpable Challenge
Surge in Tuberculosis Deaths amid COVID-19: A Wake-Up Call to Drive R&D Funding
Efforts to Integrate Testing for TB & COVID-19
Competition
Competitive Market Presence – Strong/Active/Niche/Trivial for 55 Players Worldwide in 2022 (E)
Global Market Overview and Outlook
Global Tuberculosis Testing Market Exuding High Degree of Vim & Vigor
North America Claims Commanding Revenue Share
Culture-based Tests & Hospitals: Primary Contributors to Tuberculosis Testing Market
Salient Factors Influencing Dynamism of Global Tuberculosis Testing Market
Intense Competition Drive Players to Bet on Innovations
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Global Tuberculosis Efforts to Drive the Market for Tuberculosis Testing
Molecular Diagnosis Innovations Soaking Up Limelight in the Tuberculosis Testing Arena
W.H.O Aims to Improve Access to Rapid Molecular Tests for Diagnosis of TB & Drug-Resistant TB
WHO-Endorsed Molecular Platforms & Tests
Bracing Technological Innovations, Tuberculosis Testing Moves in New Direction
Tuberculosis Screening: The Dawn of Artificial Intelligence Technology
Nanodiagnostics Set to Witness Growth in TB Testing Market
A Nanobiosensor for Rapid Detection of Mycobacterium Tuberculosis
CRISPR-based Biosensing to See Significant Growth in Pediatric Tuberculosis
Present Limitations and Future Directions
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
UNITED STATES
Tuberculosis Testing Market Presence – Strong/Active/Niche/Trivial – Key Competitors in the United States for 2022 (E)
Market Analytics
CANADA
JAPAN
CHINA
EUROPE
Tuberculosis Testing Market Presence – Strong/Active/Niche/Trivial – Key Competitors in Europe for 2022 (E)
Market Analytics
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
IV. COMPETITION
Total Companies Profiled: 55
For more information about this report visit https://www.researchandmarkets.com/r/rowvyg
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
